Aryl Hydrocarbon Receptor Interacting Protein Targets IRF7 to Suppress Antiviral Signaling and the Induction of Type I Interferon.
Qinjie Zhou, Alfonso Lavorgna, Melissa Bowman, John Hiscott, Edward W Harhaj
Index: J. Biol. Chem. 290 , 14729-39, (2015)
Full Text: HTML
Abstract
The transcription factor IRF7 (interferon regulatory factor 7) is a key regulator of type I interferon and plays essential roles in restricting virus infection and spread. IRF7 activation is tightly regulated to prevent excessive inflammation and autoimmunity; however, how IRF7 is suppressed by negative regulators remains poorly understood. Here, we have identified AIP (aryl hydrocarbon receptor interacting protein) as a new binding partner of IRF7. The interaction between AIP and IRF7 is enhanced upon virus infection, and AIP potently inhibits IRF7-induced type I IFN (IFNα/β) production. Overexpression of AIP blocks virus-induced activation of IFN, whereas knockdown of AIP by siRNA potentiates virally activated IFN production. Consistently, AIP-deficient murine embryonic fibroblasts are highly resistant to virus infection because of increased production of IFNα/β. AIP inhibits IRF7 function by antagonizing the nuclear localization of IRF7. Together, our study identifies AIP as a novel inhibitor of IRF7 and a negative regulator of innate antiviral signaling. © 2015 by The American Society for Biochemistry and Molecular Biology, Inc.
Related Compounds
Related Articles:
2014-01-01
[PLoS Biol. 12(1) , e1001758, (2014)]
Functional consequence of the MET-T1010I polymorphism in breast cancer.
2015-02-20
[Oncotarget 6(5) , 2604-14, (2015)]
Immunomodulation by the Pseudomonas syringae HopZ type III effector family in Arabidopsis.
2014-01-01
[PLoS ONE 9(12) , e116152, (2014)]
Aptamer-based polyvalent ligands for regulated cell attachment on the hydrogel surface.
2015-04-13
[Biomacromolecules 16(4) , 1382-9, (2015)]
Targeting glucose uptake with siRNA-based nanomedicine for cancer therapy.
2015-05-01
[Biomaterials 51 , 1-11, (2015)]